Stay updated on Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial page.

Latest updates to the Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe page has updated the status of results, indicating that results have been posted, while the previous date for results submitted has been removed. Additionally, there is a notice about heavy traffic affecting NLM-NCBI services.SummaryDifference7%
- Check45 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check59 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.SummaryDifference1.0%
- Check95 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial page.